U.S. market Closed. Opens in 17 hours 3 minutes

AMPH | Amphastar Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue644.39M498.99M437.77M349.85M322.36M294.67M240.18M255.16M251.52M210.46M229.68M204.32M118.36M
Cost of Revenue300.43M250.13M238.03M206.51M190.43M187.68M149.38M150.98M174.17M159.21M142.72M114.02M90.25M
Gross Profit343.97M248.86M199.74M143.34M131.92M106.98M90.80M104.19M77.35M51.26M86.96M90.30M28.10M
Operating Expenses144.28M141.36M129.85M132.39M131.96M115.61M94.33M88.50M84.04M68.80M69.34M62.81M61.58M
Selling, General & Admin80.39M66.59M68.92M65.16M63.11M58.04M50.92M47.30M46.97M40.37M36.32M31.65M30.53M
Research & Development63.89M74.77M60.93M67.23M68.85M57.56M43.41M41.20M37.06M28.43M33.02M31.16M31.05M
Other Operating Expenses-3.93M8.54M14.25M-6.32M60.27M-1.30MN/AN/AN/AN/AN/AN/AN/A
Operating Income199.69M78.76M43.13M-14.23M-39.00K-8.62M-895.00K15.69M-6.69M-17.54M17.62M27.49M-33.48M
Other Expenses / Income-28.33M37.28M41.00M18.86M60.27M-1.30M2.52M-746.00K-3.67M-604.00K-389.00K-1.61M1.59M
Before Tax Income171.36M116.04M84.14M4.64M60.23M-9.93M1.62M14.95M-10.36M-18.15M17.23M25.88M-31.89M
Income Tax Expenses31.83M23.48M20.63M3.54M13.72M-3.27M-2.88M4.41M-7.58M-7.45M5.37M7.78M-39.64M
Net Income137.54M91.39M62.12M1.10M48.94M-5.74M4.51M10.53M-2.79M-10.70M11.86M18.09M7.75M
Interest Expenses29.16M1.85M885.00K374.00K119.00K243.00K826.00K1.02M987.00K609.00K958.00K784.00K584.00K
Basic Shares Outstanding48.27M48.55M47.78M47.04M46.98M46.40M46.11M45.38M44.96M41.96M8.00M8.00M8.00M
Diluted Shares Outstanding53.00M52.43M49.78M49.12M49.91M46.40M48.37M47.50M44.96M41.96M8.00M8.00M8.00M
EBITDA241.46M107.50M69.89M10.95M-39.00K-8.62M17.89M30.53M3.88M-3.09M31.26M38.16M-20.15M
EBITDA Margin37.47%21.54%15.96%3.13%-0.01%-2.93%7.45%11.97%1.54%-1.47%13.61%18.68%-17.03%
EBIT198.54M116.71M83.63M5.01M62.78M-8.76M2.45M15.97M-9.38M-17.54M18.18M26.66M-31.30M
EBIT Margin30.81%23.39%19.10%1.43%19.48%-2.97%1.02%6.26%-3.73%-8.33%7.92%13.05%-26.45%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙